Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 23 % of short-term debt in 2025; threshold 65 %.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Medtech Group from Brussel, company number BE0716909380, closed financial year 2025 with a result of € 211,920 after tax. Compared with financial year 2024, the result moved from € -11,136 to € 211,920. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.
€ 12.3 million
▲ 2% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 211,920
▲ still € 11,136 loss in 2024
Profit after tax over the fiscal year.
€ 20,897
▲ € 15,795 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 12.2 million.
Debts at end 2025
€ 9.5 million
▲ 5% vs 2024
Loans from banks and other lenders, long and short.
€ 248,357
▲ 47% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 6282 days on average.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Profit after taxes | € 11,694,709 | € 298,435 | € -11,136 | € 211,920 | ▲ € 223,056 |
| Equity | € 11,756,503 | € 12,054,938 | € 12,043,802 | € 12,255,722 | ▲ 2% |
| Total debts | € 7,246,065 | € 8,441,818 | € 9,215,467 | € 9,751,587 | ▲ 6% |
| Cash | € 283,615 | € 425,101 | € 5,102 | € 20,897 | ▲ € 15,795 |
| Retained profit | € 11,737,903 | € 12,036,338 | € 12,025,202 | € 12,237,122 | ▲ 2% |
| Bank debt | € 7,162,693 | € 8,375,286 | € 9,046,367 | € 9,503,230 | ▲ 5% |
| Balance sheet total | € 19,002,568 | € 20,496,756 | € 21,259,268 | € 22,007,309 | ▲ 4% |
Key figures of Medtech Group, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Medtech Group?
What happened at Medtech Group in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 211,920. Source: NBB ↗
- Medtech SA stepped down as director. NBB
- Redouane Bennani stepped down as director. NBB
- New establishment in Zaventem. KBO
- Medtech SA became a director. NBB
- Redouane Bennani became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 11.7 million profit in 2022 to € 211,920 profit in 2025.
Paid € 0 in corporate taxes since 2022.
Best year ever: 2022, with € 11.7 million profit.
A new publication or filing at Medtech Group? We notify you, reason included.
Follow Medtech GroupDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
It owns 53.3% of SGEVT, 40.8% of OPPSCIENCE, 40% of AEXIS GROUP, 7.2% of Medtech sa, 0% of Aexis Belgium and 0% of Aexis International itself.
Directors
According to the 2025 annual accounts
Director · represented by Said RKAIBU
since 2018 · until 2026
Redouane Bennani
Director
since 2018 · until 2026
Establishments
Establishment units
Physical locations of this company
Bischoffsheimlaan 39 box 4
1000 Brussel
Leuvensesteenweg 392 box B
1932 Zaventem
Active since 27 December 2018
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0716.909.380
- VAT number
- BE 0716.909.380
- Registered office
- Bischoffsheimlaan 39 bus 4, 1000 Brussel
- Names & denominations
- Medtech Group
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 27 December 2018
- Peppol
- Not registered
- Contact
- [email protected]